학술논문
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
Document Type
Article
Author
Source
In The Lancet Rheumatology January 2021 3(1):e28-e39
Subject
Language
ISSN
2665-9913